Gangappa Rajashekara Babu, Kenchannavar Manjunath Basavaraj, Chowdary Prashanth Basappa, Patanki Adithya Malolan, Ishwar Mahalakshmi
Associate Professor, Department of General Surgery, Bangalore Medical College and Research Institute , Bangalore, India .
Resident, Department of General Surgery, Bangalore Medical College and Research Institute , Bangalore, India .
J Clin Diagn Res. 2016 Jun;10(6):PC04-7. doi: 10.7860/JCDR/2016/18733.7991. Epub 2016 Jun 1.
Total thyroidectomy has been used to treat patients with malignant thyroid disease. But for patients with benign thyroid disease, the safety and efficacy of total thyroidectomy is a matter of debate. Subtotal thyroidectomy that was previously the treatment of choice for benign thyroid disease has been associated with high recurrence rates. The risk of permanent complications is greatly increased in patients who undergo surgery for recurrence of benign thyroid disease. Total thyroidectomy is an operation that can be safely performed, with low incidence of permanent complications, which allows one to broaden its indications in various benign thyroid diseases, thus avoiding future recurrences and reoperations.
To assess the benefits of total thyroidectomy for benign thyroid diseases.
This randomized prospective study was conducted between Feb 2013 and Nov 2014 in the Department of General Surgery at Bangalore Medical College and Research Institute. It included 116 patients undergoing total thyroidectomy procedure for benign thyroid disease. All cases were followed-up for a period of 6 months for incidence of RLN palsy, hypoparathyroidism, disease recurrence and number of incidental malignancies detected on postoperative histological analyses of the thyroid specimens.
Most of the patients were in the third decade of their lives. The female to male ratio was 6.7:1. Total thyroidectomy was done for 116 benign thyroid diseases with multinodular goiter as the most common diagnosis. The incidence of postoperative hypocalcaemia was 16.37% (however, only 1 patient developed permanent hypocalcaemia) and that of wound infection was 2.58% and seroma formation was 2.58%. None of the patients included in this study had haematoma formation or RLN paralysis. An incidental malignancy was identified in 11.20% patients.
Total thyroidectomy shows benefits in eradicating multinodular goiter, alleviating Grave's opthalmopathy, treating Hashimoto's thyroiditis and preventing recurrence. It decreases the likelihood of future operations for recurrent disease or completion thyroidectomy for incidental thyroid cancer thus decreasing the associated risks of increased morbidity associated with second operation. Therefore, for benign thyroid diseases requiring surgical management total thyroidectomy can be considered the treatment of choice.
全甲状腺切除术已被用于治疗甲状腺恶性疾病患者。但对于甲状腺良性疾病患者,全甲状腺切除术的安全性和有效性存在争议。以前作为甲状腺良性疾病首选治疗方法的次全甲状腺切除术与高复发率相关。因良性甲状腺疾病复发而接受手术的患者发生永久性并发症的风险大大增加。全甲状腺切除术是一种可以安全实施的手术,永久性并发症发生率低,这使得可以扩大其在各种良性甲状腺疾病中的适应证,从而避免未来的复发和再次手术。
评估全甲状腺切除术治疗甲状腺良性疾病的益处。
这项随机前瞻性研究于2013年2月至2014年11月在班加罗尔医学院及研究所普通外科进行。研究包括116例因甲状腺良性疾病接受全甲状腺切除术的患者。对所有病例进行了为期6个月的随访,以观察喉返神经麻痹、甲状旁腺功能减退、疾病复发的发生率以及甲状腺标本术后组织学分析中发现的偶然恶性肿瘤的数量。
大多数患者处于第三个十年年龄段。男女比例为6.7:1。对116例甲状腺良性疾病进行了全甲状腺切除术,最常见的诊断为多结节性甲状腺肿。术后低钙血症的发生率为16.37%(然而,只有1例患者发生永久性低钙血症),伤口感染率为2.58%,血清肿形成率为2.58%。本研究纳入的患者均未发生血肿形成或喉返神经麻痹。11.20%的患者发现了偶然恶性肿瘤。
全甲状腺切除术在根除多结节性甲状腺肿、缓解格雷夫斯眼病、治疗桥本甲状腺炎和预防复发方面显示出益处。它降低了因疾病复发而未来再次手术或因偶然甲状腺癌而进行甲状腺全切术的可能性,从而降低了与二次手术相关的发病率增加的相关风险。因此,对于需要手术治疗的甲状腺良性疾病,全甲状腺切除术可被视为首选治疗方法。